Document:

EXHIBIT
10.65

 

STOWE
PHARMACEUTICALS, INC.

 

CONSULTING
AGREEMENT

 

This
Consulting Agreement (this “Agreement”) is made and entered into as of 2/13/2020 (the “Effective
Date”) by and between Stowe Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at
102 Woodmont Blvd., Suite 610, Nashville, TN 37205 (the “Company”), and Andrew R. Boll, an individual
with a principal place of business at 102 Woodmont Blvd., Suite 610, Nashville, TN 37205 (“Consultant”)
(each herein referred to individually as a “Party,” or collectively as the “Parties”).

 

The
Company desires to retain Consultant as an independent contractor to perform consulting services for the Company, and Consultant
is willing to perform such services, on the terms described below. In consideration of the mutual promises contained herein, the
Parties agree as follows:

 

1.
Services and Compensation

 

Consultant
shall perform the services described in Exhibit A (the “Services”) for the Company (or its designee),
and the Company agrees to pay Consultant the compensation described in Exhibit A for Consultant’s performance of
the Services.

 

2.
Confidentiality

 

A.
Definition of Confidential Information. “Confidential Information” means any information
(including any and all combinations of individual items of information) that relates to the actual or anticipated business and/or
products, research or development of the Company, its affiliates or subsidiaries, or to the Company’s, its affiliates’
or subsidiaries’ technical data, trade secrets, or know-how, including, but not limited to, research, product plans, or
other information regarding the Company’s, its affiliates’ or subsidiaries’ products or services and markets
therefor, customer lists and customers (including, but not limited to, customers of the Company on whom Consultant called or with
whom Consultant became acquainted during the term of this Agreement), software, developments, inventions, discoveries, ideas,
processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and
other business information disclosed by the Company, its affiliates or subsidiaries, either directly or indirectly, in writing,
orally or by drawings or inspection of premises, parts, equipment, or other property of Company, its affiliates or subsidiaries.
Notwithstanding the foregoing, Confidential Information shall not include any such information which Consultant can establish
(i) was publicly known or made generally available prior to the time of disclosure to Consultant; (ii) becomes publicly known
or made generally available after disclosure to Consultant through no wrongful action or inaction of Consultant; or (iii) is in
the rightful possession of Consultant, without confidentiality obligations, at the time of disclosure as shown by Consultant’s
then-contemporaneous written records; provided that any combination of individual items of information shall not be deemed to
be within any of the foregoing exceptions merely because one or more of the individual items are within such exception, unless
the combination as a whole is within such exception.

 

    	 

    	 

    

 

B.
Nonuse and Nondisclosure. During and after the term of this Agreement, Consultant will hold in the strictest confidence,
and take all reasonable precautions to prevent any unauthorized use or disclosure of Confidential Information, and Consultant
will not (i) use the Confidential Information for any purpose whatsoever other than as necessary for the performance of the Services
on behalf of the Company, or (ii) subject to Consultant’s right to engage in Protected Activity (as defined below), disclose
the Confidential Information to any third party without the prior written consent of an authorized representative of the Company,
except that Consultant may disclose Confidential Information to the extent compelled by applicable law; provided however,
prior to such disclosure, Consultant shall provide prior written notice to Company and seek a protective order or such similar
confidential protection as may be available under applicable law. Consultant agrees that no ownership of Confidential Information
is conveyed to the Consultant. Without limiting the foregoing, Consultant shall not use or disclose any Company property, intellectual
property rights, trade secrets or other proprietary know-how of the Company to invent, author, make, develop, design, or otherwise
enable others to invent, author, make, develop, or design identical or substantially similar designs as those developed under
this Agreement for any third party. Consultant agrees that Consultant’s obligations under this Section 2.B shall continue
after the termination of this Agreement.

 

C.
Other Client Confidential Information. Consultant agrees that Consultant will not improperly use, disclose, or induce
the Company to use any proprietary information or trade secrets of any former or current employer of Consultant or other person
or entity with which Consultant has an obligation to keep in confidence. Consultant also agrees that Consultant will not bring
onto the Company’s premises or transfer onto the Company’s technology systems any unpublished document, proprietary
information, or trade secrets belonging to any third party unless disclosure to, and use by, the Company has been consented to
in writing by such third party.

 

D.
Third Party Confidential Information. Consultant recognizes that the Company has received and in the future will
receive from third parties their confidential or proprietary information subject to a duty on the Company’s part to maintain
the confidentiality of such information and to use it only for certain limited purposes. Consultant agrees that at all times during
the term of this Agreement and thereafter, Consultant owes the Company and such third parties a duty to hold all such confidential
or proprietary information in the strictest confidence and not to use it or to disclose it to any person, firm, corporation, or
other third party except as necessary in carrying out the Services for the Company consistent with the Company’s agreement
with such third party.

 

3.
Ownership

 

A.
Assignment of Inventions. Consultant agrees that all right, title, and interest in and to any copyrightable material,
notes, records, drawings, designs, inventions, improvements, developments, discoveries, ideas and trade secrets conceived, discovered,
authored, invented, developed or reduced to practice by Consultant, solely or in collaboration with others, during the term of
this Agreement and arising out of, or in connection with, performing the Services under this Agreement and any copyrights, patents,
trade secrets, mask work rights or other intellectual property rights relating to the foregoing (collectively, “Inventions”),
are the sole property of the Company. Consultant also agrees to promptly make full written disclosure to the Company of any Inventions
and to deliver and assign (or cause to be assigned) and hereby irrevocably assigns fully to the Company all right, title and interest
in and to the Inventions.

 

B.
Pre-Existing Materials. Subject to Section 3.A, Consultant will provide the Company with prior written notice if,
in the course of performing the Services, Consultant incorporates into any Invention or utilizes in the performance of the Services
any invention, discovery, idea, original works of authorship, development, improvements, trade secret, concept, or other proprietary
information or intellectual property right owned by Consultant or in which Consultant has an interest, prior to, or separate from,
performing the Services under this Agreement (“Prior Inventions”), and the Company is hereby
granted a nonexclusive, royalty-free, perpetual, irrevocable, transferable, worldwide license (with the right to grant and authorize
sublicenses) to make, have made, use, import, offer for sale, sell, reproduce, distribute, modify, adapt, prepare derivative works
of, display, perform, and otherwise exploit such Prior Inventions, without restriction, including, without limitation, as part
of or in connection with such Invention, and to practice any method related thereto. Consultant will not incorporate any invention,
discovery, idea, original works of authorship, development, improvements, trade secret, concept, or other proprietary information
or intellectual property right owned by any third party into any Invention without Company’s prior written permission.

 

    	-2-

    	 

    

 

C.
Moral Rights. Any assignment to the Company of Inventions includes all rights of attribution, paternity, integrity,
modification, disclosure and withdrawal, and any other rights throughout the world that may be known as or referred to as “moral
rights,” “artist’s rights,” “droit moral,” or the like (collectively, “Moral Rights”).
To the extent that Moral Rights cannot be assigned under applicable law, Consultant hereby waives and agrees not to enforce any
and all Moral Rights, including, without limitation, any limitation on subsequent modification, to the extent permitted under
applicable law.

 

D.
Maintenance of Records. Consultant agrees to keep and maintain adequate, current, accurate, and authentic written
records of all Inventions made by Consultant (solely or jointly with others) during the term of this Agreement, and for a period
of three (3) years thereafter. The records will be in the form of notes, sketches, drawings, electronic files, reports, or any
other format that is customary in the industry and/or otherwise specified by the Company. Such records are and remain the sole
property of the Company at all times and upon Company’s request, Consultant shall deliver (or cause to be delivered) the
same.

 

E.
Further Assurances. Consultant agrees to assist Company, or its designee, at the Company’s expense, in every
proper way to secure the Company’s rights in Inventions in any and all countries, including the disclosure to the Company
of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments
and all other instruments that the Company may deem necessary in order to apply for, register, obtain, maintain, defend, and enforce
such rights, and in order to deliver, assign and convey to the Company, its successors, assigns and nominees the sole and exclusive
right, title, and interest in and to all Inventions and testifying in a suit or other proceeding relating to such Inventions.
Consultant further agrees that Consultant’s obligations under this Section 3.E shall continue after the termination of this
Agreement.

 

F.
Attorney-in-Fact. Consultant agrees that, if the Company is unable because of Consultant’s unavailability,
dissolution, mental or physical incapacity, or for any other reason, to secure Consultant’s signature with respect to any
Inventions, including, without limitation, for the purpose of applying for or pursuing any application for any United States or
foreign patents or mask work or copyright registrations covering the Inventions assigned to the Company in Section 3.A, then Consultant
hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Consultant’s agent
and attorney-in-fact, to act for and on Consultant’s behalf to execute and file any papers and oaths and to do all other
lawfully permitted acts with respect to such Inventions to further the prosecution and issuance of patents, copyright and mask
work registrations with the same legal force and effect as if executed by Consultant. This power of attorney shall be deemed coupled
with an interest, and shall be irrevocable.

 

    	-3-

    	 

    

 

4.
Conflicting Obligations

 

A.
Consultant represents and warrants that Consultant has no agreements, relationships, or commitments to any other person or entity
that conflict with the provisions of this Agreement, Consultant’s obligations to the Company under this Agreement, and/or
Consultant’s ability to perform the Services. Consultant will not enter into any such conflicting agreement during the term
of this Agreement.

 

B.
Consultant shall require all Consultant’s employees, contractors, or other third-parties performing Services under this
Agreement to execute a Confidential Information and Assignment Agreement in a form reasonably acceptable to the Company, and promptly
provide a copy of each such executed agreement to the Company. Consultant’s violation of this Section 4 will be considered
a material breach under Section 6.B.

 

5.
Return of Company Materials

 

Upon
the termination of this Agreement, or upon Company’s earlier request, Consultant will immediately deliver to the Company,
and will not keep in Consultant’s possession, recreate, or deliver to anyone else, any and all Company property, including,
but not limited to, Confidential Information, tangible embodiments of the Inventions, all devices and equipment belonging to the
Company, all electronically-stored information and passwords to access such property, those records maintained pursuant to Section
3.D and any reproductions of any of the foregoing items that Consultant may have in Consultant’s possession or control.

 

6.
Term and Termination

 

A.
Term. Consultant commenced providing Services to the Company on or about December 1, 2019 and shall provide the
Services through the earlier of (i) one year from the Effective Date, (ii) a Change in Control (as defined in the Company’s
2020 Equity Incentive Plan (the “Plan”)), (iii) the IPO (as defined in the Plan), (iv) a Qualified Financing
(as set forth in Exhibit A attached hereto) or (v) such earlier date as the Services are terminated by the Company or Consultant
as provided in Section 6.B (the “Term”).

 

B.
Termination. The Company may terminate this Agreement upon giving Consultant fourteen (14) days prior written notice
of such termination pursuant to Section 12.G of this Agreement. The Company may terminate this Agreement immediately and without
prior notice if Consultant refuses to or is unable to perform the Services or is in breach of any material provision of this Agreement.

 

C.
Survival. Upon any termination, all rights and duties of the Company and Consultant toward each other shall cease
except:

 

(1)
The Company will pay, within thirty (30) days after the effective date of termination, all amounts owing to Consultant for Services
completed and accepted by the Company prior to the termination date and related reimbursable expenses, if any, submitted in accordance
with the Company’s policies and in accordance with the provisions of Section 1 of this Agreement; and

 

(2)
Section 2 (Confidentiality), Section 3 (Ownership), Section 4.B (Conflicting Obligations), Section 5 (Return of Company Materials),
Section 6 (Term and Termination), Section 7 (Independent Contractor; Benefits), Section 8 (Indemnification), Section 9 (Nonsolicitation),
Section 10 (Limitation of Liability), Section 11 (Arbitration and Equitable Relief), and Section 12 (Miscellaneous) will survive
termination or expiration of this Agreement in accordance with their terms.

 

    	-4-

    	 

    

 

7.
Independent Contractor; Benefits

 

A.
Independent Contractor. It is the express intention of the Company and Consultant that Consultant perform the Services
as an independent contractor to the Company. Nothing in this Agreement shall in any way be construed to constitute Consultant
as an agent, employee or representative of the Company. Without limiting the generality of the foregoing, Consultant is not authorized
to bind the Company to any liability or obligation or to represent that Consultant has any such authority. Consultant agrees to
furnish (or reimburse the Company for) all tools and materials necessary to accomplish this Agreement and shall incur all expenses
associated with performance. Consultant acknowledges and agrees that Consultant is obligated to report as income all compensation
received by Consultant pursuant to this Agreement. Consultant agrees to and acknowledges the obligation to pay all self-employment
and other taxes on such income.

 

B.
Benefits. The Company and Consultant agree that Consultant will receive no Company-sponsored benefits from the Company
where benefits include, but are not limited to, paid vacation, sick leave, medical insurance and 401k participation. If Consultant
is reclassified by a state or federal agency or court as the Company’s employee, Consultant will become a reclassified employee
and will receive no benefits from the Company, except those mandated by state or federal law, even if by the terms of the Company’s
benefit plans or programs of the Company in effect at the time of such reclassification, Consultant would otherwise be eligible
for such benefits.

 

8.
Indemnification

 

Consultant
agrees to indemnify and hold harmless the Company and its affiliates and their directors, officers and employees from and against
all taxes, losses, damages, liabilities, costs and expenses, including attorneys’ fees and other legal expenses, arising
directly or indirectly from or in connection with (i) any negligent, reckless or intentionally wrongful act of Consultant or Consultant’s
assistants, employees, contractors or agents, (ii) a determination by a court or agency that the Consultant is not an independent
contractor, (iii) any breach by the Consultant or Consultant’s assistants, employees, contractors or agents of any of the
covenants contained in this Agreement and corresponding Confidential Information and Invention Assignment Agreement, (iv) any
failure of Consultant to perform the Services in accordance with all applicable laws, rules and regulations, or (v) any violation
or claimed violation of a third party’s rights resulting in whole, or in part, from the Company’s use of the Inventions
or other deliverables of Consultant under this Agreement.

 

9.
Nonsolicitation

 

To
the fullest extent permitted under applicable law, from the date of this Agreement until twelve (12) months after the termination
of this Agreement for any reason (the “Restricted Period”), Consultant will not, without the Company’s
prior written consent, directly or indirectly, solicit any of the Company’s employees to leave their employment, or attempt
to solicit employees of the Company, either for Consultant or for any other person or entity. Consultant agrees that nothing in
this Section 9 shall affect Consultant’s continuing obligations under this Agreement during and after this twelve (12) month
period, including, without limitation, Consultant’s obligations under Section 2.

 

    	-5-

    	 

    

 

10.
Limitation of Liability

 

IN
NO EVENT SHALL COMPANY BE LIABLE TO CONSULTANT OR TO ANY OTHER PARTY FOR ANY INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES,
OR DAMAGES FOR LOST PROFITS OR LOSS OF BUSINESS, HOWEVER CAUSED AND UNDER ANY THEORY OF LIABILITY, WHETHER BASED IN CONTRACT,
TORT (INCLUDING NEGLIGENCE) OR OTHER THEORY OF LIABILITY, REGARDLESS OF WHETHER COMPANY WAS ADVISED OF THE POSSIBILITY OF SUCH
DAMAGES AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. IN NO EVENT SHALL COMPANY’S LIABILITY
ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT EXCEED THE AMOUNTS PAID BY COMPANY TO CONSULTANT UNDER THIS AGREEMENT FOR
THE SERVICES, DELIVERABLES OR INVENTION GIVING RISE TO SUCH LIABILITY.

 

11.
Arbitration and Equitable Relief

 

A.
Arbitration.
In consideration of Consultant’s consulting relationship with THE Company,
its promise to arbitrate all disputes related to Consultant’s consulting relationship with the Company and Consultant’s
receipt of the compensation and other benefits paid to Consultant by Company, at present and in the future, Consultant agrees
that any and all controversies, claims, or disputes with anyone (including Company and any employee, officer, director, shareholder
or benefit plan of the Company in their capacity as such or otherwise), arising out of, relating to, or resulting from Consultant’s
consulting or other relationship with the Company or the termination of Consultant’s consulting or other relationship with
the Company, including any breach of this Agreement, SHALL BE SUBJECT TO BINDING ARBITRATION PURSUANT TO THE FEDERAL ARBITRATION
ACT (THE “FAA”). THE FAA’S SUBSTANTIVE AND PROCEDURAL RULES SHALL EXCLUSIVELY GOVERN AND APPLY WITH FULL FORCE
AND EFFECT TO THIS ARBITRATION AGREEMENT, INCLUDING ITS ENFORCEMENT, AND ANY STATE COURT OF COMPETENT JURISDICTION SHALL STAY
PROCEEDINGS PENDING ARBITRATION OR COMPEL ARBITRATION IN THE SAME MANNER AS A FEDERAL COURT UNDER THE FAA. CONSULTANT FURTHER
AGREES THAT, TO THE FULLEST EXTENT PERMITTED BY LAW, CONSULTANT MAY BRING ANY ARBITRATION PROCEEDING ONLY IN CONSULTANT’S
INDIVIDUAL CAPACITY, AND NOT AS A PLAINTIFF, REPRESENTATIVE, OR CLASS MEMBER IN ANY PURPORTED CLASS, COLLECTIVE, OR REPRESENTATIVE
LAWSUIT OR PROCEEDING. CONSULTANT MAY, HOWEVER, BRING A PROCEEDING AS A PRIVATE ATTORNEY GENERAL AS PERMITTED BY LAW. TO THE
FULLEST EXTENT PERMITTED BY LAW, CONSULTANT AGREES TO ARBITRATE any AND ALL COMMON LAW AND/OR statutory claims under LOCAL, state,
or federal law, including, but not limited to, claims under THE California Labor Code, CLAIMS RELATING TO EMPLOYMENT OR INDEPENDENT
CONTRACTOR STATUS, CLASSIFICATION, AND RELATIONSHIP WITH THE COMPANY, AND claims of BREACH OF CONTRACT, EXCEPT AS PROHIBITED BY
LAW. CONSULTANT ALSO AGREES TO ARBITRATE ANY AND ALL DISPUTES ARISING OUT OF OR RELATING TO THE INTERPRETATION OR APPLICATION
OF THIS AGREEMENT TO ARBITRATE, BUT NOT DISPUTES ABOUT THE ENFORCEABILITY, REVOCABILITY OR VALIDITY OF THIS AGREEMENT TO ARBITRATE
OR THE CLASS, COLLECTIVE AND REPRESENTATIVE PROCEEDING WAIVER HEREIN. WITH RESPECT TO ALL SUCH CLAIMS AND DISPUTES THAT CONSULTANT
AGREEs TO ARBITRATE, CONSULTANT HEREBY EXPRESSLY AGREES TO WAIVE, AND DOES WAIVE, ANY RIGHT TO A TRIAL BY JURY. Consultant
further understands that this Agreement to arbitrate also applies to any disputes that the Company may have with Consultant. CONSULTANT
UNDERSTANDS THAT NOTHING IN THIS AGREEMENT REQUIRES CONSULTANT TO ARBITRATE CLAIMS THAT CANNOT BE ARBITRATED UNDER APPLICABLE
LAW, SUCH AS CLAIMS UNDER THE SARBANES-OXLEY ACT.

 

    	-6-

    	 

    

 

B.
Procedure.
Consultant agrees that any arbitration will be administered by JAMS pursuant
to its EMPLOYMENT Arbitration Rules & Procedures (the “JAMS Rules”), WHICH ARE AVAILABLE AT http://www.jamsadr.com/rules-employment-arbitration/.
IF THE JAMS RULES CANNOT BE ENFORCED AS TO THE ARBITRATION, THEN THE PARTIES AGREE THAT THEY WILL ARBITRATE THIS DISPUTE UNDER
THE CALIFORNIA ARBITRATION ACT (CALIFORNIA CODE CIV. PROC. § 1280 ET. SEQ (THE “CAA”), PROVIDED, HOWEVER, THAT
NOTHING IN THIS PARAGRAPH WILL AFFECT THE APPLICABILITY OF THE FAA TO THE ENFORCEMENT OF THIS ARBITRATION AGREEMENT. CONSULTANT
AGREES THAT THE USE OF THE JAMS RULES DOES NOT CHANGE CONSULTANT’S CLASSIFICATION TO THAT OF AN EMPLOYEE. TO THE CONTRARY,
CONSULTANT REAFFIRMS THAT CONSULTANT IS AN INDEPENDENT CONTRACTOR. Consultant agrees that the arbitrator shall have the power
to decide any motions brought by any party to the arbitration, including motions for summary judgment and/or adjudication and
motions to dismiss and demurrers APPLYING THE STANDARDS SET FORTH UNDER THE CALIFORNIA CODE OF CIVIL PROCEDURE. Consultant agrees
that the arbitrator shall issue a written decision on the merits. CONSULTANT ALSO AGREES THAT THE ARBITRATOR SHALL HAVE THE POWER
TO AWARD ANY REMEDIES AVAILABLE UNDER APPLICABLE LAW, AND THAT THE ARBITRATOR SHALL AWARD ATTORNEYS’ FEES AND COSTS TO THE
PREVAILING PARTY, WHERE PERMITTED BY APPLICABLE LAW. CONSULTANT AGREES that the decree or award rendered by the arbitrator may
be entered as a final and binding judgment in any court having jurisdiction thereof. Consultant agrees that the arbitrator shall
administer and conduct any arbitration in ACCORDANCE with CALIFORNIA LAW, and that the arbitrator shall apply substantive and
procedural California law to any dispute or claim, without reference to rules of conflict of law. Consultant further agrees that
any arbitration under this agreement shall be conducted in San Diego County, california.

 

C.
Remedy.
Except as provided by the CCP ACT AND THIS AGREEMENT,
arbitration shall be the sole, exclusive, and final remedy for any dispute between Consultant and the Company. Accordingly, except
as provided for by the CCP ACT AND this agreement, neither Consultant nor the Company will be permitted to pursue court action
regarding claims that are subject to arbitration.

 

D.
Availability of Injunctive Relief.
In accordance with Rule 1281.8 of the California Code of Civil Procedure, the
Parties agree that any party may also petition the court for injunctive relief where either party alleges or claims a violation
of any agreement regarding INTELLECTUAL PROPERTY, confidential information OR NONINTERFERENCE. In the event either party seeks
injunctive relief, the prevailing party shall be entitled to recover reasonable costs and attorneys’ fees. 

 

    	-7-

    	 

    

 

E.
Administrative Relief.
Consultant understands that except as permitted by law this Agreement does
not prohibit Consultant from pursuing certain Administrative claimS with local, state or federal administrative bodIES OR GOVERNMENT
AGENCIES such as the Department of Fair Employment and Housing, the Equal Employment Opportunity Commission, the National Labor
Relations Board, or the workers’ compensation board. this agreement does, however, preclUde consultant from bringing any
alleged wage claims with the Department of labor standards enforcement. Likewise, This Agreement does preclude Consultant from
pursuing court action regarding any Administrative claims, except as permitted by law.

 

F.
Voluntary Nature of Agreement.
Consultant acknowledges and agrees that CONSULTANT is executing this Agreement
voluntarily and without any duress or undue influence by the Company or anyone else. Consultant further acknowledges and agrees
that CONSULTANT has carefully read this Agreement and that Consultant has asked any questions needed for Consultant to understand
the terms, consequences and binding effect of this Agreement and fully understand it, including that Consultant is waiving
CONSULTANT’S right to a jury trial. Finally, Consultant agrees that CONSULTANT has been provided an opportunity
to seek the advice of an attorney of Consultant’s choice before signing this Agreement.

 

12.
Miscellaneous

 

A.
Governing Law; Consent to Personal Jurisdiction. This Agreement shall be governed by the laws of the State of California,
without regard to the conflicts of law provisions of any jurisdiction. To the extent that any lawsuit is permitted under this
Agreement, the Parties hereby expressly consent to the personal and exclusive jurisdiction and venue of the state and federal
courts located in California.

 

B.
Assignability. This Agreement will be binding upon Consultant’s heirs, executors, assigns, administrators,
and other legal representatives, and will be for the benefit of the Company, its successors, and its assigns. There are no intended
third-party beneficiaries to this Agreement, except as expressly stated. Except as may otherwise be provided in this Agreement,
Consultant may not sell, assign or delegate any rights or obligations under this Agreement. Notwithstanding anything to the contrary
herein, Company may assign this Agreement and its rights and obligations under this Agreement to any successor to all or substantially
all of Company’s relevant assets, whether by merger, consolidation, reorganization, reincorporation, sale of assets or stock,
change of control or otherwise.

 

C.
Entire Agreement. This Agreement constitutes the entire agreement and understanding between the Parties with respect
to the subject matter herein and supersedes all prior written and oral agreements, discussions, or representations between the
Parties. Consultant represents and warrants that Consultant is not relying on any statement or representation not contained in
this Agreement. To the extent any terms set forth in any exhibit or schedule conflict with the terms set forth in this Agreement,
the terms of this Agreement shall control unless otherwise expressly agreed by the Parties in such exhibit or schedule.

 

    	-8-

    	 

    

 

D.
Headings. Headings are used in this Agreement for reference only and shall not be considered when interpreting this
Agreement.

 

E.
Severability. If a court or other body of competent jurisdiction finds, or the Parties mutually believe, any provision
of this Agreement, or portion thereof, to be invalid or unenforceable, such provision will be enforced to the maximum extent permissible
so as to effect the intent of the Parties, and the remainder of this Agreement will continue in full force and effect.

 

F.
Modification, Waiver. No modification of or amendment to this Agreement, nor any waiver of any rights under this
Agreement, will be effective unless in a writing signed by the Parties. Waiver by the Company of a breach of any provision of
this Agreement will not operate as a waiver of any other or subsequent breach.

 

G.
Notices. Any notice or other communication required or permitted by this Agreement to be given to a Party shall
be in writing and shall be deemed given (i) if delivered personally or by commercial messenger or courier service, (ii) when sent
by confirmed facsimile, or (iii) if mailed by U.S. registered or certified mail (return receipt requested), to the Party at the
Party’s address written below or at such other address as the Party may have previously specified by like notice. If by
mail, delivery shall be deemed effective three business days after mailing in accordance with this Section 12.G.

 

(1)
If to the Company, to:

 

Stowe
Pharmaceuticals, Inc.

102
Woodmont Blvd., Suite 610

Nashville,
TN 37205

Attention:
Chief Executive Officer

 

(2)
If to Consultant, to the address for notice on the signature page to this Agreement or, if no such address is provided, to the
last address of Consultant provided by Consultant to the Company.

 

H.
Attorneys’ Fees. In any court action at law or equity that is brought by one of the Parties to this Agreement
to enforce or interpret the provisions of this Agreement, the prevailing Party will be entitled to reasonable attorneys’
fees, in addition to any other relief to which that Party may be entitled.

 

I.
Signatures. This Agreement may be signed in two counterparts, each of which shall be deemed an original, with the
same force and effectiveness as though executed in a single document.

 

    	-9-

    	 

    

 

J.
Applicability to Past Activities. Consultant agrees that if and to the extent that Consultant provided any services
or made efforts on behalf of or for the benefit of Company, or related to the current or prospective business of Company in anticipation
of Consultant’s involvement with the Company, that would have been “Services” if performed during the term of
this Agreement (the “Prior Consulting Period”) and to the extent that during the Prior Consulting Period:
(i) Consultant received access to any information from or on behalf of Company that would have been “Confidential Information”
if Consultant received access to such information during the term of this Agreement; or (ii) Consultant (a) conceived, created,
authored, invented, developed or reduced to practice any item (including any intellectual property rights with respect thereto)
on behalf of or for the benefit of Company, or related to the current or prospective business of Company in anticipation of Consultant’s
involvement with Company, that would have been an Invention if conceived, created, authored, invented, developed or reduced to
practice during the term of this Agreement; or (b) incorporated into any such item any pre-existing invention, improvement, development,
concept, discovery or other proprietary information that would have been a Prior Invention if incorporated into such item during
the term of this Agreement; then any such information shall be deemed Confidential Information hereunder and any such item shall
be deemed an Invention or Prior Invention hereunder, and this Agreement shall apply to such activities, information or item as
if disclosed, conceived, created, authored, invented, developed or reduced to practice during the term of this Agreement. Consultant
further acknowledges that Consultant has been fully compensated for all services provided during any such Prior Consulting Period.

 

K.
Protected Activity Not Prohibited. Consultant understands that nothing in this Agreement shall in any way limit
or prohibit Consultant from engaging in any Protected Activity. For purposes of this Agreement, “Protected Activity”
shall mean filing a charge, complaint, or report with, or otherwise communicating, cooperating, or participating in any investigation
or proceeding that may be conducted by, any federal, state or local government agency or commission, including the Securities
and Exchange Commission (“Government Agencies”). Consultant understands that in connection with such
Protected Activity, Consultant is permitted to disclose documents or other information as permitted by law, and without giving
notice to, or receiving authorization from, the Company. Notwithstanding the foregoing, Consultant agrees to take all reasonable
precautions to prevent any unauthorized use or disclosure of any information that may constitute Company confidential information
to any parties other than the Government Agencies. Consultant further understands that “Protected Activity”
does not include the disclosure of any Company attorney-client privileged communications. Pursuant to the Defend Trade Secrets
Act of 2016, Consultant is notified that an individual will not be held criminally or civilly liable under any federal or state
trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state, or local government
official (directly or indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation
of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing
is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation
of law may disclose the trade secret to the individual’s attorney and use the trade secret information in the court proceeding,
if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant
to court order.

 

(signature
page follows)

 

    	-10-

    	 

    

 

IN
WITNESS WHEREOF, the Parties hereto have executed this Consulting Agreement as of the date first written above.

 

	CONSULTANT		Stowe
    Pharmaceuticals, Inc.
	 	 		 	 
	By:	/s/
    Andrew Boll		By:	/s/
    Mark Baum
	Name:	Andrew
    R. Boll	 	Name:	Mark
    L. Baum
	 	 		Title:	Executive
    Director

 

	Address
    for Notice:	 
	 	 
	 	 
	 	 
	 	 
	 	 

 

    	 

    	 

    

 

EXHIBIT
A

 

SERVICES
AND COMPENSATION

 

1.
Contact. Consultant’s principal Company contact:

 

	 	Name:	Andrew
    R. Boll	 
	 	 	 	 
	 	Title:
    	Executive
    Director	 
	 	 	 	 
	 	Email:	aboll@harrowinc.com	 
	 	 	 	 
	 	Phone:	(615)
    733-4731	 

 

2.
Services. Consultant shall provide management advisory services to the Company relating to its establishment, financing
activities and other related services as may be requested from time to time by the Company.

 

3.
Compensation. 

 

A.
Upon or shortly following commencement of Consultant’s Services to the Company, and subject to the approval of the Company’s
Board of Directors, the Company shall issue to Consultant 375,000 shares of the Company’s common stock, par value $0.0001
per share (the “Shares”). The Shares shall be subject to the terms and conditions of the Company’s
2020 Equity Incentive Plan (the “Plan”) and a restricted stock award agreement between the Company and
Consultant.

 

B.
The Shares subject to the Restricted Stock Award shall vest upon the earliest of:

 

	 	(1)	a
    Change in Control (as defined in the Plan); 
	 	 	 
	 	(2)	the
    date of any underwriting agreement between the Company and the underwriter(s) managing an initial public offering of Common
    Stock, pursuant to which the Common Stock is priced for initial public offering; or
	 	 	 
	 	(3)	the
    date of closing of a bona-fide equity financing with third party investors resulting in cash gross proceeds to the Company
    of at least $10,000,000 (the “Qualified Financing”);

 

and
in any case of (1), (2) and (3), (each, a “Vesting Event”), subject to Grantee’s continuous status
as a Service Provider (as defined in the Plan) through the date of such Vesting Event; provided, however, in the event Grantee’s
continuous status as a Service Provider (as defined in the Plan) is terminated by the Company (other than for Cause (as defined
in the Plan) or by death of Grantee) prior to the completion of any Vesting Event, the shares subject to the Restricted Stock
Award shall be deemed to have vested in accordance with the following vesting schedule: the shares shall vest in equal monthly
installments over the six (6) months following the date hereof, on the same date of the month.

 

    	 

    	 

    

 

C.
All payments and benefits provided for under this Agreement are intended to be exempt from or otherwise comply with the requirements
of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance thereunder (together, “Section
409A”), so that none of the payments and benefits to be provided hereunder will be subject to the additional tax
imposed under Section 409A, and any ambiguities or ambiguous terms herein will be interpreted to be exempt or so comply. Each
payment and benefit payable under this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2)
of the Treasury Regulations. In no event will the Company reimburse Consultant for any taxes that may be imposed on Consultant
as a result of Section 409A.

 

This
Exhibit A is accepted and agreed upon as of February 13, 2020.

 

	CONSULTANT	 	STOWE
    PHARMACEUTICALS, INC.
	 	 	 	 	 
	By:	/s/
    Andrew Boll	 	By:	/s/
    Mark BAum
	Name:	Andrew
    R. Boll	 	Name:	Mark
    L. Baum
	 	 	 	Title:	Executive
    Director

 

    	-2-EXHIBIT
10.66

 

STOWE
PHARMACEUTICALS, INC.

 

CONSULTING
AGREEMENT

 

This
Consulting Agreement (this “Agreement”) is made and entered into as of February 13, 2020 (the “Effective
Date”) by and between Stowe Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at
102 Woodmont Blvd., Suite 610, Nashville, TN 37205 (the “Company”), and John Saharek, an individual
with a principal place of business at 12264 El Camino Real, Suite 350, San Diego, CA 92130 (“Consultant”)
(each herein referred to individually as a “Party,” or collectively as the “Parties”).

 

The
Company desires to retain Consultant as an independent contractor to perform consulting services for the Company, and Consultant
is willing to perform such services, on the terms described below. In consideration of the mutual promises contained herein, the
Parties agree as follows:

 

1.
Services and Compensation

 

Consultant
shall perform the services described in Exhibit A (the “Services”) for the Company (or its designee),
and the Company agrees to pay Consultant the compensation described in Exhibit A for Consultant’s performance of
the Services.

 

2.
Confidentiality

 

A.
Definition of Confidential Information. “Confidential Information” means any information
(including any and all combinations of individual items of information) that relates to the actual or anticipated business and/or
products, research or development of the Company, its affiliates or subsidiaries, or to the Company’s, its affiliates’
or subsidiaries’ technical data, trade secrets, or know-how, including, but not limited to, research, product plans, or
other information regarding the Company’s, its affiliates’ or subsidiaries’ products or services and markets
therefor, customer lists and customers (including, but not limited to, customers of the Company on whom Consultant called or with
whom Consultant became acquainted during the term of this Agreement), software, developments, inventions, discoveries, ideas,
processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and
other business information disclosed by the Company, its affiliates or subsidiaries, either directly or indirectly, in writing,
orally or by drawings or inspection of premises, parts, equipment, or other property of Company, its affiliates or subsidiaries.
Notwithstanding the foregoing, Confidential Information shall not include any such information which Consultant can establish
(i) was publicly known or made generally available prior to the time of disclosure to Consultant; (ii) becomes publicly known
or made generally available after disclosure to Consultant through no wrongful action or inaction of Consultant; or (iii) is in
the rightful possession of Consultant, without confidentiality obligations, at the time of disclosure as shown by Consultant’s
then-contemporaneous written records; provided that any combination of individual items of information shall not be deemed to
be within any of the foregoing exceptions merely because one or more of the individual items are within such exception, unless
the combination as a whole is within such exception.

 

    	 

    	 

    

 

B.
Nonuse and Nondisclosure. During and after the term of this Agreement, Consultant will hold in the strictest confidence,
and take all reasonable precautions to prevent any unauthorized use or disclosure of Confidential Information, and Consultant
will not (i) use the Confidential Information for any purpose whatsoever other than as necessary for the performance of the Services
on behalf of the Company, or (ii) subject to Consultant’s right to engage in Protected Activity (as defined below), disclose
the Confidential Information to any third party without the prior written consent of an authorized representative of the Company,
except that Consultant may disclose Confidential Information to the extent compelled by applicable law; provided however,
prior to such disclosure, Consultant shall provide prior written notice to Company and seek a protective order or such similar
confidential protection as may be available under applicable law. Consultant agrees that no ownership of Confidential Information
is conveyed to the Consultant. Without limiting the foregoing, Consultant shall not use or disclose any Company property, intellectual
property rights, trade secrets or other proprietary know-how of the Company to invent, author, make, develop, design, or otherwise
enable others to invent, author, make, develop, or design identical or substantially similar designs as those developed under
this Agreement for any third party. Consultant agrees that Consultant’s obligations under this Section 2.B shall continue
after the termination of this Agreement.

 

C.
Other Client Confidential Information. Consultant agrees that Consultant will not improperly use, disclose, or induce
the Company to use any proprietary information or trade secrets of any former or current employer of Consultant or other person
or entity with which Consultant has an obligation to keep in confidence. Consultant also agrees that Consultant will not bring
onto the Company’s premises or transfer onto the Company’s technology systems any unpublished document, proprietary
information, or trade secrets belonging to any third party unless disclosure to, and use by, the Company has been consented to
in writing by such third party.

 

D.
Third Party Confidential Information. Consultant recognizes that the Company has received and in the future will
receive from third parties their confidential or proprietary information subject to a duty on the Company’s part to maintain
the confidentiality of such information and to use it only for certain limited purposes. Consultant agrees that at all times during
the term of this Agreement and thereafter, Consultant owes the Company and such third parties a duty to hold all such confidential
or proprietary information in the strictest confidence and not to use it or to disclose it to any person, firm, corporation, or
other third party except as necessary in carrying out the Services for the Company consistent with the Company’s agreement
with such third party.

 

3.
Ownership

 

A.
Assignment of Inventions. Consultant agrees that all right, title, and interest in and to any copyrightable material,
notes, records, drawings, designs, inventions, improvements, developments, discoveries, ideas and trade secrets conceived, discovered,
authored, invented, developed or reduced to practice by Consultant, solely or in collaboration with others, during the term of
this Agreement and arising out of, or in connection with, performing the Services under this Agreement and any copyrights, patents,
trade secrets, mask work rights or other intellectual property rights relating to the foregoing (collectively, “Inventions”),
are the sole property of the Company. Consultant also agrees to promptly make full written disclosure to the Company of any Inventions
and to deliver and assign (or cause to be assigned) and hereby irrevocably assigns fully to the Company all right, title and interest
in and to the Inventions.

 

B.
Pre-Existing Materials. Subject to Section 3.A, Consultant will provide the Company with prior written notice if,
in the course of performing the Services, Consultant incorporates into any Invention or utilizes in the performance of the Services
any invention, discovery, idea, original works of authorship, development, improvements, trade secret, concept, or other proprietary
information or intellectual property right owned by Consultant or in which Consultant has an interest, prior to, or separate from,
performing the Services under this Agreement (“Prior Inventions”), and the Company is hereby
granted a nonexclusive, royalty-free, perpetual, irrevocable, transferable, worldwide license (with the right to grant and authorize
sublicenses) to make, have made, use, import, offer for sale, sell, reproduce, distribute, modify, adapt, prepare derivative works
of, display, perform, and otherwise exploit such Prior Inventions, without restriction, including, without limitation, as part
of or in connection with such Invention, and to practice any method related thereto. Consultant will not incorporate any invention,
discovery, idea, original works of authorship, development, improvements, trade secret, concept, or other proprietary information
or intellectual property right owned by any third party into any Invention without Company’s prior written permission.

 

    	-2-

    	 

    

 

C.
Moral Rights. Any assignment to the Company of Inventions includes all rights of attribution, paternity, integrity,
modification, disclosure and withdrawal, and any other rights throughout the world that may be known as or referred to as “moral
rights,” “artist’s rights,” “droit moral,” or the like (collectively, “Moral Rights”).
To the extent that Moral Rights cannot be assigned under applicable law, Consultant hereby waives and agrees not to enforce any
and all Moral Rights, including, without limitation, any limitation on subsequent modification, to the extent permitted under
applicable law.

 

D.
Maintenance of Records. Consultant agrees to keep and maintain adequate, current, accurate, and authentic written
records of all Inventions made by Consultant (solely or jointly with others) during the term of this Agreement, and for a period
of three (3) years thereafter. The records will be in the form of notes, sketches, drawings, electronic files, reports, or any
other format that is customary in the industry and/or otherwise specified by the Company. Such records are and remain the sole
property of the Company at all times and upon Company’s request, Consultant shall deliver (or cause to be delivered) the
same.

 

E.
Further Assurances. Consultant agrees to assist Company, or its designee, at the Company’s expense, in every
proper way to secure the Company’s rights in Inventions in any and all countries, including the disclosure to the Company
of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments
and all other instruments that the Company may deem necessary in order to apply for, register, obtain, maintain, defend, and enforce
such rights, and in order to deliver, assign and convey to the Company, its successors, assigns and nominees the sole and exclusive
right, title, and interest in and to all Inventions and testifying in a suit or other proceeding relating to such Inventions.
Consultant further agrees that Consultant’s obligations under this Section 3.E shall continue after the termination of this
Agreement.

 

F.
Attorney-in-Fact. Consultant agrees that, if the Company is unable because of Consultant’s unavailability,
dissolution, mental or physical incapacity, or for any other reason, to secure Consultant’s signature with respect to any
Inventions, including, without limitation, for the purpose of applying for or pursuing any application for any United States or
foreign patents or mask work or copyright registrations covering the Inventions assigned to the Company in Section 3.A, then Consultant
hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Consultant’s agent
and attorney-in-fact, to act for and on Consultant’s behalf to execute and file any papers and oaths and to do all other
lawfully permitted acts with respect to such Inventions to further the prosecution and issuance of patents, copyright and mask
work registrations with the same legal force and effect as if executed by Consultant. This power of attorney shall be deemed coupled
with an interest, and shall be irrevocable.

 

    	-3-

    	 

    

 

4.
Conflicting Obligations

 

A.
Consultant represents and warrants that Consultant has no agreements, relationships, or commitments to any other person or entity
that conflict with the provisions of this Agreement, Consultant’s obligations to the Company under this Agreement, and/or
Consultant’s ability to perform the Services. Consultant will not enter into any such conflicting agreement during the term
of this Agreement.

 

B.
Consultant shall require all Consultant’s employees, contractors, or other third-parties performing Services under this
Agreement to execute a Confidential Information and Assignment Agreement in a form reasonably acceptable to the Company, and promptly
provide a copy of each such executed agreement to the Company. Consultant’s violation of this Section 4 will be considered
a material breach under Section 6.B.

 

5.
Return of Company Materials

 

Upon
the termination of this Agreement, or upon Company’s earlier request, Consultant will immediately deliver to the Company,
and will not keep in Consultant’s possession, recreate, or deliver to anyone else, any and all Company property, including,
but not limited to, Confidential Information, tangible embodiments of the Inventions, all devices and equipment belonging to the
Company, all electronically-stored information and passwords to access such property, those records maintained pursuant to Section
3.D and any reproductions of any of the foregoing items that Consultant may have in Consultant’s possession or control.

 

6.
Term and Termination

 

A.
Term. Consultant commenced providing Services to the Company on or about December 1, 2019 and shall provide the
Services through the earlier of (i) one year from the Effective Date, (ii) a Change in Control (as defined in the Company’s
2020 Equity Incentive Plan (the “Plan”)), (iii) the IPO (as defined in the Plan), (iv) a Qualified Financing
(as set forth in Exhibit A attached hereto) or (v) such earlier date as the Services are terminated by the Company or Consultant
as provided in Section 6.B (the “Term”).

 

B.
Termination. The Company may terminate this Agreement upon giving Consultant fourteen (14) days prior written notice
of such termination pursuant to Section 12.G of this Agreement. The Company may terminate this Agreement immediately and without
prior notice if Consultant refuses to or is unable to perform the Services or is in breach of any material provision of this Agreement.

 

C.
Survival. Upon any termination, all rights and duties of the Company and Consultant toward each other shall cease
except:

 

(1)
The Company will pay, within thirty (30) days after the effective date of termination, all amounts owing to Consultant for Services
completed and accepted by the Company prior to the termination date and related reimbursable expenses, if any, submitted in accordance
with the Company’s policies and in accordance with the provisions of Section 1 of this Agreement; and

 

(2)
Section 2 (Confidentiality), Section 3 (Ownership), Section 4.B (Conflicting Obligations), Section 5 (Return of Company Materials),
Section 6 (Term and Termination), Section 7 (Independent Contractor; Benefits), Section 8 (Indemnification), Section 9 (Nonsolicitation),
Section 10 (Limitation of Liability), Section 11 (Arbitration and Equitable Relief), and Section 12 (Miscellaneous) will survive
termination or expiration of this Agreement in accordance with their terms.

 

    	-4-

    	 

    

 

7.
Independent Contractor; Benefits

 

A.
Independent Contractor. It is the express intention of the Company and Consultant that Consultant perform the Services
as an independent contractor to the Company. Nothing in this Agreement shall in any way be construed to constitute Consultant
as an agent, employee or representative of the Company. Without limiting the generality of the foregoing, Consultant is not authorized
to bind the Company to any liability or obligation or to represent that Consultant has any such authority. Consultant agrees to
furnish (or reimburse the Company for) all tools and materials necessary to accomplish this Agreement and shall incur all expenses
associated with performance. Consultant acknowledges and agrees that Consultant is obligated to report as income all compensation
received by Consultant pursuant to this Agreement. Consultant agrees to and acknowledges the obligation to pay all self-employment
and other taxes on such income.

 

B.
Benefits. The Company and Consultant agree that Consultant will receive no Company-sponsored benefits from the Company
where benefits include, but are not limited to, paid vacation, sick leave, medical insurance and 401k participation. If Consultant
is reclassified by a state or federal agency or court as the Company’s employee, Consultant will become a reclassified employee
and will receive no benefits from the Company, except those mandated by state or federal law, even if by the terms of the Company’s
benefit plans or programs of the Company in effect at the time of such reclassification, Consultant would otherwise be eligible
for such benefits.

 

8.
Indemnification

 

Consultant
agrees to indemnify and hold harmless the Company and its affiliates and their directors, officers and employees from and against
all taxes, losses, damages, liabilities, costs and expenses, including attorneys’ fees and other legal expenses, arising
directly or indirectly from or in connection with (i) any negligent, reckless or intentionally wrongful act of Consultant or Consultant’s
assistants, employees, contractors or agents, (ii) a determination by a court or agency that the Consultant is not an independent
contractor, (iii) any breach by the Consultant or Consultant’s assistants, employees, contractors or agents of any of the
covenants contained in this Agreement and corresponding Confidential Information and Invention Assignment Agreement, (iv) any
failure of Consultant to perform the Services in accordance with all applicable laws, rules and regulations, or (v) any violation
or claimed violation of a third party’s rights resulting in whole, or in part, from the Company’s use of the Inventions
or other deliverables of Consultant under this Agreement.

 

9.
Nonsolicitation

 

To
the fullest extent permitted under applicable law, from the date of this Agreement until twelve (12) months after the termination
of this Agreement for any reason (the “Restricted Period”), Consultant will not, without the Company’s
prior written consent, directly or indirectly, solicit any of the Company’s employees to leave their employment, or attempt
to solicit employees of the Company, either for Consultant or for any other person or entity. Consultant agrees that nothing in
this Section 9 shall affect Consultant’s continuing obligations under this Agreement during and after this twelve (12) month
period, including, without limitation, Consultant’s obligations under Section 2

 

    	-5-

    	 

    

 

10.
Limitation of Liability

 

IN
NO EVENT SHALL COMPANY BE LIABLE TO CONSULTANT OR TO ANY OTHER PARTY FOR ANY INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES,
OR DAMAGES FOR LOST PROFITS OR LOSS OF BUSINESS, HOWEVER CAUSED AND UNDER ANY THEORY OF LIABILITY, WHETHER BASED IN CONTRACT,
TORT (INCLUDING NEGLIGENCE) OR OTHER THEORY OF LIABILITY, REGARDLESS OF WHETHER COMPANY WAS ADVISED OF THE POSSIBILITY OF SUCH
DAMAGES AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. IN NO EVENT SHALL COMPANY’S LIABILITY
ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT EXCEED THE AMOUNTS PAID BY COMPANY TO CONSULTANT UNDER THIS AGREEMENT FOR
THE SERVICES, DELIVERABLES OR INVENTION GIVING RISE TO SUCH LIABILITY.

 

11.
Arbitration and Equitable Relief

 

A. Arbitration. In
consideration of Consultant’s consulting relationship with THE Company, its promise to arbitrate all disputes related
to Consultant’s consulting relationship with the Company and Consultant’s receipt of the compensation and other
benefits paid to Consultant by Company, at present and in the future, Consultant agrees that any and all controversies,
claims, or disputes with anyone (including Company and any employee, officer, director, shareholder or benefit plan of the
Company in their capacity as such or otherwise), arising out of, relating to, or resulting from Consultant’s consulting
or other relationship with the Company or the termination of Consultant’s consulting or other relationship with the
Company, including any breach of this Agreement, SHALL BE SUBJECT TO BINDING ARBITRATION PURSUANT TO THE FEDERAL ARBITRATION
ACT (THE “FAA”). THE FAA’S SUBSTANTIVE AND PROCEDURAL RULES SHALL EXCLUSIVELY GOVERN AND APPLY WITH FULL
FORCE AND EFFECT TO THIS ARBITRATION AGREEMENT, INCLUDING ITS ENFORCEMENT, AND ANY STATE COURT OF COMPETENT JURISDICTION
SHALL STAY PROCEEDINGS PENDING ARBITRATION OR COMPEL ARBITRATION IN THE SAME MANNER AS A FEDERAL COURT UNDER THE FAA.
CONSULTANT FURTHER AGREES THAT, TO THE FULLEST EXTENT PERMITTED BY LAW, CONSULTANT MAY BRING ANY ARBITRATION PROCEEDING ONLY
IN CONSULTANT’S INDIVIDUAL CAPACITY, AND NOT AS A PLAINTIFF, REPRESENTATIVE, OR CLASS MEMBER IN ANY PURPORTED CLASS,
COLLECTIVE, OR REPRESENTATIVE LAWSUIT OR PROCEEDING. CONSULTANT MAY, HOWEVER, BRING A PROCEEDING AS A PRIVATE ATTORNEY
GENERAL AS PERMITTED BY LAW. TO THE FULLEST EXTENT PERMITTED BY LAW, CONSULTANT AGREES TO ARBITRATE any AND ALL COMMON LAW
AND/OR statutory claims under LOCAL, state, or federal law, including, but not limited to, claims under THE California Labor
Code, CLAIMS RELATING TO EMPLOYMENT OR INDEPENDENT CONTRACTOR STATUS, CLASSIFICATION, AND RELATIONSHIP WITH THE COMPANY, AND
claims of BREACH OF CONTRACT, EXCEPT AS PROHIBITED BY LAW. CONSULTANT ALSO AGREES TO ARBITRATE ANY AND ALL DISPUTES ARISING
OUT OF OR RELATING TO THE INTERPRETATION OR APPLICATION OF THIS AGREEMENT TO ARBITRATE, BUT NOT DISPUTES ABOUT THE
ENFORCEABILITY, REVOCABILITY OR VALIDITY OF THIS AGREEMENT TO ARBITRATE OR THE CLASS, COLLECTIVE AND REPRESENTATIVE
PROCEEDING WAIVER HEREIN. WITH RESPECT TO ALL SUCH CLAIMS AND DISPUTES THAT CONSULTANT AGREEs TO ARBITRATE, CONSULTANT HEREBY
EXPRESSLY AGREES TO WAIVE, AND DOES WAIVE, ANY RIGHT TO A TRIAL BY JURY. Consultant further understands that this
Agreement to arbitrate also applies to any disputes that the Company may have with Consultant. CONSULTANT UNDERSTANDS THAT
NOTHING IN THIS AGREEMENT REQUIRES CONSULTANT TO ARBITRATE CLAIMS THAT CANNOT BE ARBITRATED UNDER APPLICABLE LAW, SUCH AS
CLAIMS UNDER THE SARBANES-OXLEY ACT.

 

    	-6-

    	 

    

 

B.
Procedure.
Consultant agrees that any arbitration will be administered by JAMS pursuant
to its EMPLOYMENT Arbitration Rules & Procedures (the “JAMS Rules”), WHICH ARE AVAILABLE AT http://www.jamsadr.com/rules-employment-arbitration/.
IF THE JAMS RULES CANNOT BE ENFORCED AS TO THE ARBITRATION, THEN THE PARTIES AGREE THAT THEY WILL ARBITRATE THIS DISPUTE UNDER
THE CALIFORNIA ARBITRATION ACT (CALIFORNIA CODE CIV. PROC. § 1280 ET. SEQ (THE “CAA”), PROVIDED, HOWEVER, THAT
NOTHING IN THIS PARAGRAPH WILL AFFECT THE APPLICABILITY OF THE FAA TO THE ENFORCEMENT OF THIS ARBITRATION AGREEMENT. CONSULTANT
AGREES THAT THE USE OF THE JAMS RULES DOES NOT CHANGE CONSULTANT’S CLASSIFICATION TO THAT OF AN EMPLOYEE. TO THE CONTRARY,
CONSULTANT REAFFIRMS THAT CONSULTANT IS AN INDEPENDENT CONTRACTOR. Consultant agrees that the arbitrator shall have the power
to decide any motions brought by any party to the arbitration, including motions for summary judgment and/or adjudication and
motions to dismiss and demurrers APPLYING THE STANDARDS SET FORTH UNDER THE CALIFORNIA CODE OF CIVIL PROCEDURE. Consultant agrees
that the arbitrator shall issue a written decision on the merits. CONSULTANT ALSO AGREES THAT THE ARBITRATOR SHALL HAVE THE POWER
TO AWARD ANY REMEDIES AVAILABLE UNDER APPLICABLE LAW, AND THAT THE ARBITRATOR SHALL AWARD ATTORNEYS’ FEES AND COSTS TO THE
PREVAILING PARTY, WHERE PERMITTED BY APPLICABLE LAW. CONSULTANT AGREES that the decree or award rendered by the arbitrator may
be entered as a final and binding judgment in any court having jurisdiction thereof. Consultant agrees that the arbitrator shall
administer and conduct any arbitration in ACCORDANCE with CALIFORNIA LAW, and that the arbitrator shall apply substantive and
procedural California law to any dispute or claim, without reference to rules of conflict of law. Consultant further agrees that
any arbitration under this agreement shall be conducted in San Diego County, california.

 

C. Remedy. Except
as provided by the CCP ACT AND THIS AGREEMENT, arbitration shall be the sole,
exclusive, and final remedy for any dispute between Consultant and the Company. Accordingly, except as provided for by the
CCP ACT AND this agreement, neither Consultant nor the Company will be permitted to pursue court action regarding claims that
are subject to arbitration. 

 

D. Availability
of Injunctive Relief. In
accordance with Rule 1281.8 of the CALIFORNIA CODE of Civil Procedure, the Parties agree that any party may also petition the
court for injunctive relief where either party alleges or claims a violation of any agreement regarding INTELLECTUAL
PROPERTY, confidential information OR NONINTERFERENCE. In the event either party seeks injunctive relief, the prevailing
party shall be entitled to recover reasonable costs and attorneys’ fees.

 

    	-7-

    	 

    

 

E. Administrative
Relief. Consultant understands
that except as permitted by law this Agreement does not prohibit Consultant from pursuing certain Administrative claimS with
local, state or federal administrative bodIES OR GOVERNMENT AGENCIES such as the Department of Fair Employment and Housing,
the Equal Employment Opportunity Commission, the National Labor Relations Board, or the workers’ compensation board.
this agreement does, however, preclUde consultant from bringing any alleged wage claims with the Department of labor
standards enforcement. Likewise, This Agreement does preclude Consultant from pursuing court action regarding any
Administrative claims, except as permitted by law.

 

F. Voluntary
Nature of Agreement.
Consultant acknowledges and agrees that CONSULTANT is executing this Agreement voluntarily and without any duress or undue
influence by the Company or anyone else. Consultant further acknowledges and agrees that CONSULTANT has carefully read this
Agreement and that Consultant has asked any questions needed for Consultant to understand the terms, consequences and binding
effect of this Agreement and fully understand it, including that Consultant is waiving CONSULTANT’S right to a
jury trial. Finally, Consultant agrees that CONSULTANT has been provided an opportunity to seek the advice of an
attorney of Consultant’s choice before signing this Agreement.

 

12.
Miscellaneous

 

A. Governing
Law; Consent to Personal Jurisdiction. This Agreement shall be governed by the laws of the State of California,
without regard to the conflicts of law provisions of any jurisdiction. To the extent that any lawsuit is permitted under this
Agreement, the Parties hereby expressly consent to the personal and exclusive jurisdiction and venue of the state and federal
courts located in California.

 

B. Assignability. This
Agreement will be binding upon Consultant’s heirs, executors, assigns, administrators, and other legal representatives,
and will be for the benefit of the Company, its successors, and its assigns. There are no intended third-party beneficiaries
to this Agreement, except as expressly stated. Except as may otherwise be provided in this Agreement, Consultant may not
sell, assign or delegate any rights or obligations under this Agreement. Notwithstanding anything to the contrary herein,
Company may assign this Agreement and its rights and obligations under this Agreement to any successor to all or
substantially all of Company’s relevant assets, whether by merger, consolidation, reorganization, reincorporation, sale
of assets or stock, change of control or otherwise.

 

C. Entire
Agreement. This Agreement constitutes the entire agreement and understanding between the Parties with respect to the
subject matter herein and supersedes all prior written and oral agreements, discussions, or representations between the
Parties. Consultant represents and warrants that Consultant is not relying on any statement or representation not contained
in this Agreement. To the extent any terms set forth in any exhibit or schedule conflict with the terms set forth in this
Agreement, the terms of this Agreement shall control unless otherwise expressly agreed by the Parties in such exhibit or
schedule.

 

    	-8-

    	 

    

 

D. Headings. Headings
are used in this Agreement for reference only and shall not be considered when interpreting this Agreement.

 

E. Severability. If
a court or other body of competent jurisdiction finds, or the Parties mutually believe, any provision of this Agreement, or
portion thereof, to be invalid or unenforceable, such provision will be enforced to the maximum extent permissible so as to
effect the intent of the Parties, and the remainder of this Agreement will continue in full force and effect.

 

F. Modification,
Waiver. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be
effective unless in a writing signed by the Parties. Waiver by the Company of a breach of any provision of this Agreement
will not operate as a waiver of any other or subsequent breach.

 

G. Notices. Any
notice or other communication required or permitted by this Agreement to be given to a Party shall be in writing and shall be
deemed given (i) if delivered personally or by commercial messenger or courier service, (ii) when sent by confirmed
facsimile, or (iii) if mailed by U.S. registered or certified mail (return receipt requested), to the Party at the
Party’s address written below or at such other address as the Party may have previously specified by like notice. If by
mail, delivery shall be deemed effective three business days after mailing in accordance with this Section 12.G.

 

(1)
If to the Company, to:

 

Stowe
Pharmaceuticals, Inc.

102
Woodmont Blvd., Suite 610

Nashville,
TN 37205

Attention:
Chief Executive Officer

 

(2)
If to Consultant, to the address for notice on the signature page to this Agreement or, if no such address is provided, to
the last address of Consultant provided by Consultant to the Company.

 

H. Attorneys’
Fees. In any court action at law or equity that is brought by one of the Parties to this Agreement to enforce or
interpret the provisions of this Agreement, the prevailing Party will be entitled to reasonable attorneys’ fees, in
addition to any other relief to which that Party may be entitled.

 

I. Signatures. This
Agreement may be signed in two counterparts, each of which shall be deemed an original, with the same force and effectiveness
as though executed in a single document.

 

    	-9-

    	 

    

 

J. Applicability
to Past Activities. Consultant agrees that if and to the extent that Consultant provided any services or made efforts
on behalf of or for the benefit of Company, or related to the current or prospective business of Company in anticipation of
Consultant’s involvement with the Company, that would have been “Services” if performed during the term of
this Agreement (the “Prior Consulting Period”) and to the extent that during the Prior Consulting
Period: (i) Consultant received access to any information from or on behalf of Company that would have been
“Confidential Information” if Consultant received access to such information during the term of this Agreement;
or (ii) Consultant (a) conceived, created, authored, invented, developed or reduced to practice any item (including any
intellectual property rights with respect thereto) on behalf of or for the benefit of Company, or related to the current or
prospective business of Company in anticipation of Consultant’s involvement with Company, that would have been an
Invention if conceived, created, authored, invented, developed or reduced to practice during the term of this Agreement; or
(b) incorporated into any such item any pre-existing invention, improvement, development, concept, discovery or other
proprietary information that would have been a Prior Invention if incorporated into such item during the term of this
Agreement; then any such information shall be deemed Confidential Information hereunder and any such item shall be deemed an
Invention or Prior Invention hereunder, and this Agreement shall apply to such activities, information or item as if
disclosed, conceived, created, authored, invented, developed or reduced to practice during the term of this Agreement.
Consultant further acknowledges that Consultant has been fully compensated for all services provided during any such Prior
Consulting Period.

 

K. Protected
Activity Not Prohibited. Consultant understands that nothing in this Agreement shall in any way limit or prohibit
Consultant from engaging in any Protected Activity. For purposes of this Agreement, “Protected
Activity” shall mean filing a charge, complaint, or report with, or otherwise communicating, cooperating, or
participating in any investigation or proceeding that may be conducted by, any federal, state or local government agency or
commission, including the Securities and Exchange Commission (“Government Agencies”). Consultant
understands that in connection with such Protected Activity, Consultant is permitted to disclose documents or other
information as permitted by law, and without giving notice to, or receiving authorization from, the Company. Notwithstanding
the foregoing, Consultant agrees to take all reasonable precautions to prevent any unauthorized use or disclosure of any
information that may constitute Company confidential information to any parties other than the Government Agencies.
Consultant further understands that “Protected Activity” does not include the disclosure of any
Company attorney-client privileged communications. Pursuant to the Defend Trade Secrets Act of 2016, Consultant is notified
that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the
disclosure of a trade secret that (i) is made in confidence to a federal, state, or local government official (directly or
indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or
(ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made
under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation
of law may disclose the trade secret to the individual’s attorney and use the trade secret information in the court
proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade
secret, except pursuant to court order.

 

(signature
page follows)

 

    	-10-

    	 

    

 

IN
WITNESS WHEREOF, the Parties hereto have executed this Consulting Agreement as of the date first written above.

 

	CONSULTANT	 	Stowe
    Pharmaceuticals, Inc.
	 	 	 
	By:	/s/
    John Saharek	 	By:	/s/
    Andrew Boll
	Name:	John
    Saharek	 	Name:	Andrew
    R. Boll
	 	 	 	Title:	Executive
    Director

 

	Address
    for Notice:	 
	102
    Woodmont Blvd. Suite 610	 
	Nashville,
    TN 37205	 
	 	 

 

    	 

    	 

    

 

EXHIBIT
A

 

SERVICES
AND COMPENSATION

 

1.
Contact. Consultant’s principal Company contact:

 

	 	Name:	Andrew
    R. Boll	 
	 	 	 	 
	 	Title:	Executive
    Director	 
	 	 	 	 
	 	Email:	aboll@harrowinc.com	 
	 	 	 	 
	 	Phone:	(615)
    733-4731	 

 

2.
Services. Consultant shall provide advisory services to the Company relating to its sales and marketing activities
and other related services as may be requested from time to time by the Company.

 

3.
Compensation.

 

A.
Subject to the approval of the Company’s board of directors (the “Board”) and the approval of
a valuation of the Company’s common stock (“Common Stock”) sufficient to satisfy the requirements
of Section 409A of the Internal Revenue Code of 1986, the Company will grant Consultant a nonqualified stock option to purchase
25,000 shares of Common Stock (the “Shares”) at a price per share equal to the fair market value per
share of the Common Stock on the date of grant, as determined by the Board. The Shares will be subject to the terms and conditions
of the Company’s 2020 Equity Incentive Plan (the “Plan”) and a stock option agreement between
Consultant and the Company.

 

B.
The shares subject to the Options shall immediately vest upon the earliest of:

 

	 	(1)	a
    Change in Control (as defined in the Plan); 
	 	 	 
	 	(2)	the
    date of any underwriting agreement between the Company and the underwriter(s) managing an initial public offering of Common
    Stock, pursuant to which the Common Stock is priced for initial public offering; or
	 	 	 
	 	(3)	the
    date of closing of a bona-fide equity financing with third party investors resulting in cash gross proceeds to the Company
    of at least $10,000,000 (the “Qualified Financing”);

 

and
in any case of (1), (2) and (3) (each, a “Vesting Event”), subject to Consultant’s continuous
status as a Service Provider (as defined in the Plan) through the date of such Vesting Event.

 

    	 

    	 

    

 

C.
All payments and benefits provided for under this Agreement are intended to be exempt from or otherwise comply with the
requirements of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance thereunder
(together, “Section 409A”), so that none of the payments and
benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any
ambiguities or ambiguous terms herein will be interpreted to be exempt or so comply. Each payment and benefit payable under
this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury
Regulations. In no event will the Company reimburse Consultant for any taxes that may be imposed on Consultant as a result of
Section 409A.

 

This
Exhibit A is accepted and agreed upon as of February 13, 2020.

 

	CONSULTANT	 	STOWE
    PHARMACEUTICALS, INC.
	 	 	 
	By:	/s/
    John Saharek	 	By:	/s/
    Andrew Boll
	Name:
    	John
    Saharek	 	Name:	Andrew
    R. Boll
	 	 	 	Title:	Executive
    Director

 

    	-2-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}]]